Oxford/AstraZeneca Covid shot less effective against South African variant – study

  • 📰 inquirerdotnet
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 86%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

“Oxford University and AstraZeneca have started adapting the vaccine against this variant and will advance rapidly through clinical development so that it is ready for Autumn delivery should it be needed,” the AstraZeneca spokesman said. | Reuters

“In this small phase I/II trial, early data has shown limited efficacy against mild disease primarily due to the B.1.351 South African variant,” an AstraZeneca spokesman said in response to the FT report.“However, we have not been able to properly ascertain its effect against severe disease and hospitalization given that subjects were predominantly young healthy adults,” the AstraZeneca spokesman said.

The trial, which involved 2,026 people of whom half formed the placebo group, has not been peer-reviewed, the FT said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Reuters So it is like an app update - so if you already got an astra vax - do you need or can you still get a newer update? 🤔

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.